Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Harpreet Grewal

Clinical Cardiac Electrophysiology Mechanicsville, VA Medical Doctor

NPI 1093826083 CMS profile 231561

8243 Meadowbridge Road, Mechanicsville, VA 23116

Open in the dashboard

General payments

$60,531

273 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$102,485 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Harpreet Grewal of Mechanicsville, VA is reported in the CMS Open Payments database as having received $60,531 across 273 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $102,485 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 80th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,929 45
2024 General $1,906 35
2023 General $18,193 50
2022 General $5,522 22
2021 General $4,586 28
2020 General $185 8
2019 General $20,209 85

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Harpreet Grewal
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Harpreet Grewal were reported at $9,929. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Harpreet Grewal Clinical Cardiac Electrophysiology median Middle half National median
2019 $20,209 $2,361 $585–$8,260 $163
2020 $185 $993 $247–$4,351 $114
2021 $4,586 $1,185 $326–$4,739 $132
2022 $5,522 $2,073 $554–$6,789 $149
2023 $18,193 $2,568 $759–$8,159 $160
2024 $1,906 $2,557 $703–$7,403 $164
2025 $9,929 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $37,188 108 payments
  2. Janssen Pharmaceuticals, Inc $12,012 17 payments
  3. Medtronic, Inc. $3,551 23 payments
  4. Atricure, Inc. $1,683 7 payments
  5. Biosense Webster, Inc. $1,336 9 payments
  6. Philips Electronics North America Corporation $1,243 13 payments
  7. Medical Device Business Services, Inc. $1,077 5 payments
  8. Abbott Laboratories $687 10 payments
  9. Impulse Dynamics (USA) Inc. $473 8 payments
  10. Medtronic Vascular, Inc. $272 13 payments
  11. Other $1,008 60 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,350 18 payments
  2. Consulting Fee $22,050 9 payments
  3. Food and Beverage $8,485 219 payments
  4. Travel and Lodging $5,641 26 payments
  5. Education $5 1 payment
Products named General payments · program years 2019–2025
  1. XARELTO $12,012 17 payments
  2. General - Therapies General - Therapies_CRM $9,121 16 payments
  3. General Therapies Therapies $4,831 15 payments
  4. General - Therapies General - Therapies_EP $3,000 1 payment
  5. Micra $2,723 12 payments
  6. GENERAL THERAPIES Pain Management $2,113 2 payments
  7. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $1,672 6 payments
  8. GENERAL THERAPIES General Therapies $1,210 6 payments
  9. Carto 3 $1,124 6 payments
  10. (9124) LM Undivided $1,116 7 payments
  11. Other $6,955 184 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

268

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$82,783

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

62.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 50 $53,074
Xarelto Rivaroxaban Brand 30 $27,756
Clopidogrel Clopidogrel Bisulfate Brand 87 $1,031
Amiodarone Hcl Generic 52 $533
Metoprolol Succinate Generic 37 $239
Carvedilol Generic 12 $149

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$656,485

Medicare's payments for the services billed

Medicare patients

1,147

Average age 78

Services billed

9,510

561 women, 586 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 67%
Arthritis 50%
Ischemic heart disease 49%
Heart failure 45%
Chronic kidney disease 41%
Diabetes 38%
Depression 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LEQVIO
  • Novartis Pharmaceuticals Corporation $37
$38 — —
ENTRESTO
  • Novartis Pharmaceuticals Corporation $37
$38 — —
ELIQUIS
  • PFIZER INC. $14
$14 50 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

273 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record